article thumbnail

Does the Drug Shortage White Paper Fall Short?

The FDA Law Blog

Department of Health and Human Services (HHS) recently published a White Paper on Policy Considerations to Prevent Drug Shortages and Mitigate Supply Chain Vulnerabilities in the United States —with input from several HHS stakeholders, including FDA, CMS, and the Administration for Strategic Preparedness and Response. By Kalie E.

FDA 59
article thumbnail

Pharma Marketing Strategies: Unlocking Success in a Competitive Industry

Pharma Marketing Network

Include valuable content like case studies, dosage calculators, and patient testimonials. Provide white papers, clinical study summaries, and even infographics that are easy to digest. Embracing Digital Transformation The digital revolution has redefined pharma marketing. Websites and SEO Your website is your digital storefront.

Dosage 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Innovative Healthcare Advertising Strategies: Transforming Pharma Marketing in the Digital Era

Pharma Marketing Network

White Papers and Webinars: Provide HCPs with resources that dive into drug efficacy and research. Instagram for Patients: Use visuals to simplify complex topics, like dosage instructions or potential side effects. Imagine a diabetes patient sharing their experience with Ozempicit resonates far better than generic ads.

Dosage 52
article thumbnail

A Systemwide Approach to Managing the Risks of Continuous Manufacturing

ISPE

For much of the pharmaceutical industry, batch manufacturing (BM) processes that have been relied upon for decades remain the preferred approach for most oral solid dosage (OSD) drug products. Office of Pharmaceutical Quality (OPQ) White Paper. March 2023. www.fda.gov/media/165775/download 7 US Food and Drug Administration.

article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

Ultimately, the summary was not adopted during the QbD pilot, but was reintroduced in 2014 when a Pharmaceutical Research and Manufacturers of America (PhRMA) team prepared a white paper describing the content and format of an improved Module 2. CPP 26 GMP Compression tooling (PQS) CPP 2 IPC Tablet hardness (P.3.4)

article thumbnail

A Proposal for a Comprehensive Quality Overall Summary

ISPE

Ultimately, the summary was not adopted during the QbD pilot, but was reintroduced in 2014 when a Pharmaceutical Research and Manufacturers of America (PhRMA) team prepared a white paper describing the content and format of an improved Module 2. CPP 26 GMP Compression tooling (PQS) CPP 2 IPC Tablet hardness (P.3.4)

article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

POD is suitable for a wide range of products, including oral solid dosage forms, mAbs, and cell therapy. Review: Continuous Manufacturing of Small Molecule Solid Oral Dosage Forms.” EFPIA White Paper on CMC Development, Manufacture and Supply of Pandemic COVID-19 Therapies and Vaccines.” doi:10.1016/j.jbiotec.2015.06.388